These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Anticoagulants in venous thromboembolism. Prophylactic and therapeutic use. Hirsh J; Gallus AS Postgrad Med; 1974 Jan; 55(1):211-7. PubMed ID: 4588719 [No Abstract] [Full Text] [Related]
11. Relation between the time to achieve the lower limit of the APTT therapeutic range and recurrent venous thromboembolism during heparin treatment for deep vein thrombosis. Hull RD; Raskob GE; Brant RF; Pineo GF; Valentine KA Arch Intern Med; 1997 Dec 8-22; 157(22):2562-8. PubMed ID: 9531224 [TBL] [Abstract][Full Text] [Related]
14. A prospective study of the value of monitoring heparin treatment with the activated partial thromboplastin time. Basu D; Gallus A; Hirsh J; Cade J N Engl J Med; 1972 Aug; 287(7):324-7. PubMed ID: 5041701 [No Abstract] [Full Text] [Related]
15. Prevention of venous thromboembolism in surgical patients. Clagett GP; Salzman EW N Engl J Med; 1974 Jan; 290(2):93-6. PubMed ID: 4585841 [No Abstract] [Full Text] [Related]
16. Anticoagulants: the state of the art. Gallus AS Aust Fam Physician; 1982 Jan; 11(1):14-22. PubMed ID: 7065989 [TBL] [Abstract][Full Text] [Related]
17. Secondary prophylaxis of venous thromboembolism: rational use of oral anticoagulants. Piovella F; Siragusa S; Barone M; Beltrametti C; Carbone S; Vicentini L; Ascari E Haematologica; 1995; 80(2 Suppl):87-91. PubMed ID: 7543072 [No Abstract] [Full Text] [Related]
18. Comparison of the relative efficacy and safety of low molecular weight heparin and unfractionated heparin for the treatment of venous thrombosis. Hirsh J Haemostasis; 1996 Oct; 26 Suppl 4():189-98. PubMed ID: 8979124 [TBL] [Abstract][Full Text] [Related]